PERTINENT FINDINGS: This study successfully developed [64Cu]Cu-NOTA-EV-F(ab′)2, which demonstrated rapid tumor accumulation, high specificity, and excellent T/B contrast in nectin-4–overexpressing TNBC and UBC models, with peak tumor uptake observed within 4 h after injection. The gene discussed is NECTIN4; the disease is neoplasm.